Pitches · 8:00–9:30 AM PT
Origami Surgical
John Hironimus, CEO · jhironimus@origamisurgical.com
Origami Surgical is a surgical device company focused on solving a significant challenge in robotic surgery. StitchKit provides greater surgeon autonomy, improved surgical workflow and increased patient safety in robotic surgical procedures.
Round
$3,000,000 Priced Round @ $14.81M Pre
Closed
0
FDA milestone
Approval
FDA timeline
Already approved
Other groups in round
SSVP
DD package
yes
Traction: Strategic partnership with Baxter Advanced Surgery kicked off February 17th, 2026
What they're looking for: Advisors at the hospital administration level
Sonaro
Karina Gasbarrino, CEO · karina.gasbarrino@sonaro-ai.com
Health-tech startup revolutionizing vascular imaging to better predict and prevent stroke. Our flagship product is a device-agnostic AI-powered software that integrates seamlessly into existing clinical workflows and converts standard 2D ultrasound into a 3D vascular imaging tool in under 10 minutes, no specialized operator expertise required, to give clinicians clearer and faster insights into patient risk for timely, targeted intervention and preventative care.
Round
$800,000 USD Convertible Note @ Pre: $4.5M USD
Closed
40%
FDA milestone
FDA pre-sub completed Jan 2025; 510(k) Class II pathway and predicate devices confirmed. Second FDA pre-sub scheduled for April 2026 to de-risk submission. Multi-centre U.S. study (targeting 100 patient enrolment and five clinical sites) launched in June 2025 in partnership with Dr. Taj (Vice-Chair Radiology, Johns Hopkins) and partially funded by Dr. Cardoso (Registered Vascular Technologist & CEO of Universal Ultrasound); Vaso3D delivers clinical results (n=40) on par with expert radiologists while reducing scan-to-report time by 90%.
FDA timeline
FDA submission planned for Q4-2026 and anticipated approval for Q1-2027.
Other groups in round
Canadian angel investor groups (SheBoot, Montreal General Hospital Foundation, WEL Manitoba Fund, OKGN WMAN)
DD package
not yet but will be available shortly
Traction: Established a strategic partnership and supply agreement with Northern Digital Inc. to integrate globally recognized tracking technology into Sonaro’s platform. Advancing partnership discussions with major ultrasound manufacturers (i.e., GE Healthcare, Clarius) to support pilots and future deployment and commercialization.
What they're looking for: Advisors with strong medtech commercialization experience; Clinical advisors / KOLs in vascular imaging, radiology, and stroke prevention; Introductions to outpatient imaging centers or vascular labs interested in pilot deployments
Neosoma
Ken Kolodziej, CEO · ken.kolodziej@neosomainc.com
Medical device software for brain tumor analysis, measurement, and tracking.
Round
$3000000 Priced Round @ $14,500,000 pre-money
Closed
$2,000,000
FDA milestone
510(k) clearance x 2 devices
FDA timeline
Cleared and in market
Other groups in round
Launchpad (Boston); Alliance of Angels (Seattle), TCA
DD package
Yes (Launchpad)
Traction: Recurring clinical revenue
What they're looking for: Customer (physician) introductions